Full Press Release Details
SAN DIEGO, Nov. 27, 2023 (GLOBE NEWSWIRE) -- Turnstone Biologics Corp. (“Turnstone”) (Nasdaq: TSBX), a clinical-stage biotechnology company developing a differentiated approach to treat and cure patients with solid tumors by pioneering selected tumor-infiltrating lymphocyte (Selected TIL) therapy, today announced that Sammy Farah, M.B.A., Ph.D., Turnstone’s President and Chief Executive Officer, will participate in the Piper Sandler 35th Annual Healthcare Conference taking place November 28 – 30, 2023 in New York, NY.
Details of participation are as follows:
Date: Thursday, November 30, 2023
Time: 1:00pm ET / 10:00am PT
Location: The Lotte New York Palace
A live webcast of the fireside chat may be accessed on the Events page of Turnstone’s Investor Relations website at https://ir.turnstonebio.com, where a replay will also be available for a limited period.
Institutional investors interested in meeting with members of Turnstone’s senior management team during the conference may contact their Piper Sandler representatives for further information.
Tags
Selected TIL Therapy
Tumor-Infiltrating Lymphocytes